​
Design, Interaction and Synthesis of Bioactive Compounds
Associate professor of Organic Chemistry and DISCOBAC coordinator
Her interests lie in the fields of Bioorganic Chemistry, Medicinal Chemistry and Chemical Biology. In particular, she focuses on the development of structurally complex multivalent drugs derived from the conjugation of organic and/or metallo-organic molecules with either carbohydrates, steroid or oligonucleotides as potential non-conventional antitumor agents.
Associate professor of Inorganic Chemistry and DISCOBAC coordinator
Her interests lie in the field of Bioinorganic Chemistry, especially in the design of multifunctional, group 8-11 metal compounds that can act as potential anticancer agents. She focuses on those chemical properties of metal compounds that could explain the role played by metal ions in the biological environment.
Gude & Royo's Lab
Full Professor of Inorganic Chemistry
Tomás Cuenca supports our team with a strong background and knowledge in Organometallic and Coordination Chemistry.
Associate Professor of Organic Chemistry
Her current research interests focus on the design of bioconjugates based on steroids and oligonucleotides as active targeted anticancer drug delivery systems.
Assistant Professor of Organic Chemistry
His research interests focus on the design of chemical compounds and bioactive ligands for novel anticancer therapies and tissue engineering.
Distinguished Senior Researcher
Talento 1 CAM
Noelia's research interests are focused on the modification and assembly of carbon nanostructures to develop novel biosensors for the detection of biologically active molecules.
Ph.D. student, Doctoral FPU MICINN Fellow
Her research aims to design new metal compounds with high binding affinities for G4-DNA as novel theragnostic anticancer agents.
Ph.D. student
Patricia's research is mainly focused on the design and synthesis of new potential antitumor organic and metallo-organic compounds, including the study of DNA-ligand interactions and biological activity.
Ph.D student, CAM-FPI Fellow
Ana is currently wotking on the design of new anticancer bioconjugates
